SCHEMBL5463158

SCHEMBL5463158

Cc1nc(N)nc2c1C(=O)CC(c1ccccc1-c1cccc(NS(C)(=O)=O)c1)C2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 5/20 0.53
HSP90AB1 P08238 4/20 0.53
ADRA2A P08913 1/20 0.51
ADRA1A P35348 1/20 0.51
IKBKB O14920 1/20 0.41
CHUK O15111 1/20 0.41
BRD4 O60885 4/20 0.41
CREBBP Q92793 1/20 0.41
PTK2 Q05397 1/20 0.40
ALDH1A1 P00352 4/20 0.39
HTT P42858 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 2/20 0.39
GAA P10253 1/20 0.39
THRB P10828 1/20 0.39
ATR Q13535 1/20 0.38
KDM4E B2RXH2 2/20 0.38
MAPT P10636 1/20 0.38
NPC1 O15118 1/20 0.38
JAK2 O60674 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5472446 0.87 HSP90AA1 (0.53) HSP90AA1HSP90AB1ADRA2AADRA1ABRD4
SCHEMBL14582311 0.85 HSP90AA1 (0.60) HSP90AA1HSP90AB1ALDH1A1SMN1; SMN2RAB9A
SCHEMBL14582312 0.84 HSP90AA1 (0.58) HSP90AA1HSP90AB1ALDH1A1SMN1; SMN2
SCHEMBL1780605 0.84 HSP90AA1 (0.70) HSP90AA1HSP90AB1BRD4ALDH1A1HTT
SCHEMBL14582445 0.82 HSP90AA1 (0.55) HSP90AA1HSP90AB1BRD4ALDH1A1SMN1; SMN2
SCHEMBL14582357 0.82 HSP90AA1 (0.55) HSP90AA1HSP90AB1IKBKBBRD4ALDH1A1
SCHEMBL5466848 0.82 HSP90AA1 (0.55) HSP90AA1HSP90AB1BRD4CREBBPALDH1A1
SCHEMBL5465100 0.82 HSP90AA1 (0.55) HSP90AA1HSP90AB1ADRA2AADRA1ABRD4
SCHEMBL14582323 0.82 HSP90AA1 (0.55) HSP90AA1HSP90AB1ALDH1A1LMNAGAA
SCHEMBL5457927 0.81 HSP90AA1 (0.53) HSP90AA1HSP90AB1ADRA2AADRA1ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070027150-A1 2-Amino-quinazolin-5-ones NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2007-02-01 US disclosed
US-20070027150-A1 2-Amino-quinazolin-5-ones NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027150-A1 2-Amino-quinazolin-5-ones TK1, TK2, SLC1A5 HSP90AA1 3373/4885HSP90AB1 3036/4885ADRA2A 827/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.